Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FiiRST-2: Clotting Factor Concentrates vs Standard Massive Hemorrhage Protocol in Trauma Patients
NCT04534751Phase 4Terminated
- Sponsor
- University Health Network
- Start
- Apr 2021
- Primary completion
- Mar 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Fibrinogen human, coagulation factor X human in traumatic hemorrhage, sponsored by University Health Network. Started Apr 2021; status: terminated.
02
Drugs
Fibrinogen humancoagulation factor X human
03
Conditions
traumatic hemorrhage
Beyond the preview
Go deeper on NCT04534751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04534751.